Calciphylaxis Market 2017-2023 | Amgen Inc., Smith & Nephew plc, Medtronics, 3M, BSN Medical,
The Global Calciphylaxis Market is expected to grow at a CAGR of 10.70% during the forecast period 2017-2023.
Major Players in the Calciphylaxis Market:
Some of the key players in this market are Amgen Inc., Smith & Nephew plc, Medtronics, 3M, BSN Medical, ConvaTec Inc, Sanifit, and others.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/3567
A number options are available in the market for the treatment of calciphylaxis, which is associated with hypophosphatemia, and secondary hyperparathyroidism with chronic kidney disease. These include bisphosphonates, newer non-calcium/non-aluminum-containing phosphate binders and case reports of use of cinacalcet. Other treatments for calcific uremic arteriolopathy (CUA) that are not targeted directly at calcium/phosphate homeostasis include HBOT and the sodium thiosulphate. The healthcare professionals have stated that randomized controlled trials for treatments in CUA are still lacking, which has restrained the growth of the market.
Warfarin is an oral anticoagulant which inhibits the synthesis of vitamin K- dependent clotting factors. Warfarin is most commonly prescribed cardiovascular agent. However, excess use of anticoagulant increases the risk of calciphylaxis in treatment seeking population. According to the national pharmaceutical regulatory agency (2015), cases of calciphylaxis have been reported in patients on warfarin therapy. Although many of the cases reported for pre-existing renal disease. Also, in May 2016, European Medicine Agency review concluded that there is reasonable possibility between calciphylaxis and use of warfarin.
The global calciphylaxis market is segmented on the basis of diagnosis, treatment, and end user. On the basis of the diagnosis, the calciphylaxis market is further segmented into deep skin biopsies, blood tests, imaging, and others. The deep skin biopsies are further segmented into shave biopsy, punch biopsy, and excisional biopsy. The blood tests is further segmented into serum parathormone levels, blood glucose levels, BUN (blood urea nitrogen), calcium levels, and others. Imaging is further segmented into magnetic resonance imaging (MRI), CT scan, ultrasound, and others. On the basis of the applications, the market is segmented into intensive wound care, medication, therapy, clot-dissolving, and others. Intensive wound care unit is further segmented into debridement, wet dressings, and others. The medication is further segmented into cinacalcet, sodium thiosulfate, steroids, and bisphosphonates. On the basis of end user, it is segmented into hospitals, clinics, medical research centers, academic institutes, and others.
The Global Calciphylaxis Market consists of four regions the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas account for a major share of the market owing to the presence of patient population, well-developed technology, high healthcare expenditure and the presence of the leading players. Moreover, due to the high prevalence of end stage renal diseases (ESRD) on of the major cause of calciphylaxis in U.S. As per The Regents of the University of California, the rate of ESRD is increasing in the U.S. by 5% per year. The American calciphylaxis market is expected to reach USD 1,257 million by 2023 from USD 581.9 million in 2016.
Europe consists of two regions namely Western Europe and Eastern Europe. Western Europe consists of countries namely Germany, the U.K., France, Italy, Spain, and Rest of Western Europe. Increasing prevalence of cardiovascular calcification in ESRD patients is a key driver for the growth of this market in Europe. Moreover, increasing healthcare expenditure, rising research & development activities, awareness among patients about the treatment options supporting the market growth for calciphylaxis.
Asia Pacific consists of Japan, China, India, Australia, Republic of Korea, and rest of Asia Pacific. Increasing incidence of chronic kidney failure across Asia Pacific. Moreover, the growth of this segment is attributed to high population growth, increasing environmental pollution, and urbanization. Increasing incidence of calciphylaxis, improving healthcare infrastructure and rising awareness about the treatment process have spurred the growth of Asia Pacific region.
On the other hand, the Middle East & Africa owns the minimum market share of the calciphylaxis market due to less development in the healthcare services such as new and advanced diagnosis & treatment methods in healthcare domain.
TABLE OF CONTENTS
1 Report Prologue
2 Market Introduction
2.2 Scope Of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.5 Market Structure
3 Research Methodology: Calciphylaxis Market
3.1 Research Process
3.2 Market Size Estimation
3.2.1 Market Share Analysis
3.3 Forecast Model
4 Market Dynamics
4.1.1 Increasing Patients Population With Renal Failure
4.1.2 Increasing Use Of Warfarin Therapy
4.2.1 Lack Of Treatment Availability
4.2.2 Higher Cost Of Existing Treatment
4.3.1 Development Of Innovative Drugs
4.3.2 Research And Development
4.4 Mega Trends
4.4.1 Improved Treatment For Hyperparathyroidism
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
4.6.1 Improvement In Novel Therapies
Full Report Details @ https://www.marketresearchfuture.com/reports/calciphylaxis-market-3567
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Phone: +1 646 845 9312
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Calciphylaxis Market 2017-2023 | Amgen Inc., Smith & Nephew plc, Medtronics, 3M, BSN Medical, here
News-ID: 1429128 • Views: 213
More Releases from Market Research Future
Reusable Satellite Launch Vehicle (RSLV) Market 2019-2023 | Report Information b …
Global Reusable Satellite Launch Vehicle Market Report Information by Configuration (Single Stage, Multiple Stage), by Type (Partially Reusable, Fully Reusable), Vehicle Weight (Up to 4,000lbs, 4000-9000lbs, Over 9000lbs), & by Region - Forecast Till 2023 The Reusable satellite launch vehicle market is estimated to witness a CAGR of more than 12% during the forecast period from 2018 to 2023. The key players in the reusable satellite launch vehicle market are Airbus S.A.S
Bakery Enzymes Market Global Research Report and Top Key Players: AB Enzymes Gmb …
Market Overview The increasing demand for bakery products in the food and beverage industry including, bread, cookies, and pastries are raising the demand for bakery enzymes at a global level. Enzymes are an important ingredient used in most bakery products. There are two scenarios regarding the use of enzymes, either the enzymes are used to convert the raw material into the main product, or the enzymes are used as additives to
Commercial Airport Lighting Market 2019-2023 | Worldwide Overview By Technology, …
Global Commercial Airport Lighting Market Research Report: Information by Technology (LED, Non-LED), by Application (Airside Lighting, Terminal Lighting, Landside Lighting), and by Region — Forecast till 2023 Honeywell International Inc., (US), ADB SAFEGATE (US), ABB (Switzerland), vosla GmBH (Germany), Avlite (Australia), Carmanah (Canada), Eaton (Ireland), atg airports limited (UK), Avionics Group (US), and HELLA GmBH & Co. KGaA (Germany) are some of the prominent players profiled in MRFR Analysis and are
Dairy By Products Market 2019-2023 | Global Top Key Player Review: Nestle S.A. ( …
Dairy By-Products Market – Overview The escalation in the level of dairy production has increased the supply of dairy by-products significantly. Market reports associated with the Food, Beverages & Nutrition industry have been made available by Market Research Future who publishes reports on other sectors that have been presently published along with a report on this industry. The market is set to expand at a positive CAGR rate in the forecast
More Releases for Calciphylaxis
Calciphylaxis Treatment Market – Product Modifications Overview 2028 | Laborat …
Global Calciphylaxis Treatment Market: Overview The rising prevalence of calcific uremic arteriolopathy (CUA) in patients with renal failure, this can be important factor influencing demand for the global calciphylaxis treatment market. This condition is also recognized in the patient diagnosed with the non-uremic patients. This can be another key reason for the market growth at global level. Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=4239 The global market for calciphylaxis treatment can be
Calciphylaxis Treatment Market Competitive Landscape 2018-2028 : Laboratoris San …
Global Calciphylaxis Treatment Market: Overview The rising prevalence of calcific uremic arteriolopathy (CUA) in patients with renal failure, this can be important factor influencing demand for the global calciphylaxis treatment market. This condition is also recognized in the patient diagnosed with the non-uremic patients. This can be another key reason for the market growth at global level. The global market for calciphylaxis treatment can be categorized on the basis of end user,
Calciphylaxis Treatment Market Report: Global Industry Assesmenent and Forcast t …
Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), is a rare condition characterized by calcification or the aggregation of calcium in a patient’s blood vessels and the development of thrombosis. This can lead to the death of cells in a patient’s skin and fatty tissues, thereby causing death. It is seen mostly in people with end-stage kidney disease but can occur in the earlier stages of chronic kidney disease and
Calciphylaxis Market Top Key players-Amgen Inc., Smith & Nephew plc, Medtronics …
Market Scenario Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), is a syndrome associated with end-stage renal disease. The syndrome causes necrotic skin ulcers, which often leads to a fatal outcome. In 2008, Rogers and Coates stated that CUA is a rare but important cause of morbidity and mortality in patients with chronic kidney disease. The prevalence of CUA is increasing in patients with renal failure, and the condition is
Calciphylaxis Market Segments, Key Players Strategies, Analysis and Forecasts Ti …
The Global Calciphylaxis Market report titled “Calciphylaxis Market Research Report-Forecast to 2023″ is a specialist investigation report by Market Research Future includes broad essential research alongside the definite examination of subjective and additionally quantitative perspectives by different industry specialists, key sentiment pioneers to pick up a more profound understanding of the market and industry execution. Considering all these factors The World Calciphylaxis Market research report was around US$ 2250.0 million
Calciphylaxis Market 2017: Key Players – 3M, BSN medical, Centurion Medical Pr …
The Worldwide Calciphylaxis Market inquire about report is developing with the quick pace; chiefly due the prospering Healthcare Sector. As per a current report distributed by the Market Research Future, The World Calciphylaxis Industry Research report is blasting and anticipated that would pick up unmistakable quality over the conjecture time frame. The Market is anticipated to exhibit a colossal development by 2023, outperforming its past development records as far as